Literature DB >> 15948818

Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.

C-L Lu1, F-Y Chang, H-C Lang, C-Y Chen, J-C Luo, S-D Lee.   

Abstract

BACKGROUND: Little is known about the gender effect on irritable bowel syndrome in Asia. AIM: To assess the gender difference in Chinese subjects with irritable bowel syndrome meeting Rome II criteria.
METHODS: Irritable bowel syndrome was identified from an apparently healthy adult population receiving a routine health maintenance program (n = 2018).
RESULTS: Female gender is not a factor associated with irritable bowel syndrome or irritable bowel syndrome-related health care-seeking behaviour. Female irritable bowel syndrome subjects, irrespective of consulting behaviour for irritable bowel syndrome, are likely to have < 3 bowel movements/week, hard/lumpy stools and abdominal fullness/bloating (P < 0.05). Female irritable bowel syndrome subjects are prone to be absent from school/work with more days of absenteeism, irrespective of consultation status (P < 0.05). Only female irritable bowel syndrome consulters have more absenteeism for their irritable bowel syndrome-related symptoms, reporting more sleep disturbances than their male counterparts (P < 0.001).
CONCLUSIONS: In an apparent healthy adult population in Taiwan, gender difference is present in Rome II defined Chinese subjects with irritable bowel syndrome as regards bowel symptoms, social impact and sleep quality. Female predominance was not found in irritable bowel syndrome subjects and irritable bowel syndrome-related health care-seeking behaviour in the current population. Both irritable bowel syndrome non-consulters and consulters have similar gender difference profiles in presenting symptoms, suggesting that bowel symptoms per se may not be the only factor leading to health care-seeking behaviour. The gender differences in sleep problems were observed solely in irritable bowel syndrome consulter.

Entities:  

Mesh:

Year:  2005        PMID: 15948818     DOI: 10.1111/j.1365-2036.2005.02512.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

1.  Prevalence of constipation in the German population - a representative survey (GECCO).

Authors:  Paul Enck; Johannes Leinert; Menno Smid; Thorsten Köhler; Juliane Schwille-Kiuntke
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

2.  So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea.

Authors:  Seung Ku Lee; Dae Wui Yoon; Hyeryeon Yi; Si Woo Lee; Jong Yeol Kim; Jin Kwan Kim; Jeong Hwa Hong; Chol Shin
Journal:  J Altern Complement Med       Date:  2014-08-22       Impact factor: 2.579

3.  Sleep Quality in Ulcerative Colitis: Associations with Inflammation, Psychological Distress, and Quality of Life.

Authors:  Megan M Hood; Rebecca Wilson; Annika Gorenz; Sharon Jedel; Shohreh Raeisi; Stevan Hobfoll; Ali Keshavarzian
Journal:  Int J Behav Med       Date:  2018-10

4.  Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

Authors:  M A Adeyemo; B M R Spiegel; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-07-22       Impact factor: 8.171

5.  A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients.

Authors:  Kyung Sik Park; Sung Hun Ahn; Jae Seok Hwang; Kwang Bum Cho; Woo Jin Chung; Byung Kuk Jang; Yu Na Kang; Jung Hyeok Kwon; Young Hwan Kim
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

6.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

7.  Irritable bowel syndrome and negative appendectomy: a prospective multivariable investigation.

Authors:  Ching-Liang Lu; Chun-Chu Liu; Jong-Ling Fuh; Pei-Yi Liu; Chew-Wun Wu; Full-Young Chang; Shou-Dong Lee
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

Review 8.  Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.

Authors:  Full-Young Chang
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  The evaluation of otilonium bromide treatment in asian patients with irritable bowel syndrome.

Authors:  Full-Young Chang; Ching-Liang Lu; Jiing-Chyuan Luo; Tseng-Shing Chen; Mei-Jung Chen; Hsiu-Ju Chang
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

10.  Irritable bowel syndrome and migraine: bystanders or partners?

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.